111 related articles for article (PubMed ID: 25260353)
1. Evaluation of the reporting level to detect triamcinolone acetonide misuse in sports.
Matabosch X; Pozo OJ; Pérez-Mañá C; Papaseit E; Marcos J; Segura J; Ventura R
J Steroid Biochem Mol Biol; 2015 Jan; 145():94-102. PubMed ID: 25260353
[TBL] [Abstract][Full Text] [Related]
2. Additional studies on triamcinolone acetonide use and misuse in sports: Elimination profile after intranasal and high-dose intramuscular administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pérez-Mañá C; Ventura R
Steroids; 2019 Nov; 151():108464. PubMed ID: 31344406
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of triamcinolone acetonide metabolites in human urine by liquid chromatography/tandem mass spectrometry after intramuscular administration.
Matabosch X; Pozo OJ; Papaseit E; Farré M; Marcos J; Segura J; Ventura R
Rapid Commun Mass Spectrom; 2014 Aug; 28(16):1829-39. PubMed ID: 25559453
[TBL] [Abstract][Full Text] [Related]
4. Positive doping results caused by the single-dose local injection of triamcinolone acetonide.
Chang CW; Huang TY; Tseng YC; Chang-Chien GP; Lin SF; Hsu MC
Forensic Sci Int; 2014 Nov; 244():1-6. PubMed ID: 25126738
[TBL] [Abstract][Full Text] [Related]
5. Elimination profiles of betamethasone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pérez-Mañá C; Ventura R
Drug Test Anal; 2021 Feb; 13(2):348-359. PubMed ID: 32949107
[TBL] [Abstract][Full Text] [Related]
6. Elimination profile of triamcinolone hexacetonide and its metabolites in human urine and plasma after a single intra-articular administration.
Coll S; Matabosch X; Llorente-Onaindia J; Carbó ML; Pérez-Mañá C; Monfort N; Monfort J; Ventura R
Drug Test Anal; 2019 Nov; 11(11-12):1589-1600. PubMed ID: 31087549
[TBL] [Abstract][Full Text] [Related]
7. Discrimination of prohibited oral use from authorized inhaled treatment of budesonide in sports.
Matabosch X; Pozo OJ; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
Ther Drug Monit; 2013 Feb; 35(1):118-28. PubMed ID: 23318282
[TBL] [Abstract][Full Text] [Related]
8. Urinary profile of methylprednisolone and its metabolites after oral and topical administrations.
Matabosch X; Pozo OJ; Monfort N; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
J Steroid Biochem Mol Biol; 2013 Nov; 138():214-21. PubMed ID: 23792784
[TBL] [Abstract][Full Text] [Related]
9. Budesonide use and misuse in sports: Elimination profiles of budesonide and metabolites after intranasal, high-dose inhaled and oral administrations.
Coll S; Monfort N; Matabosch X; Papakonstantinou K; Pérez-Mañá C; Mateus JA; Ventura R
Drug Test Anal; 2020 May; 12(5):629-636. PubMed ID: 31306564
[TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of prednisolone metabolites in human urine by LC-MS/MS.
Matabosch X; Pozo OJ; Pérez-Mañá C; Papaseit E; Segura J; Ventura R
J Mass Spectrom; 2015 Mar; 50(3):633-42. PubMed ID: 25800201
[TBL] [Abstract][Full Text] [Related]
11. Elimination profiles of prednisone and prednisolone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pozo OJ; Pérez-Mañá C; Ventura R
Drug Test Anal; 2021 Mar; 13(3):571-582. PubMed ID: 33161623
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses.
Knych HK; Vidal MA; Casbeer HC; McKemie DS
Equine Vet J; 2013 Nov; 45(6):715-20. PubMed ID: 23574452
[TBL] [Abstract][Full Text] [Related]
13. Identification of budesonide metabolites in human urine after oral administration.
Matabosch X; Pozo OJ; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
Anal Bioanal Chem; 2012 Aug; 404(2):325-40. PubMed ID: 22573060
[TBL] [Abstract][Full Text] [Related]
14. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
15. Effect of glucocorticoid administration on the steroid profile.
Coll S; Matabosch X; Garrostas L; Perez-Maña C; Ventura R
Drug Test Anal; 2018 Jun; 10(6):947-955. PubMed ID: 29278450
[TBL] [Abstract][Full Text] [Related]
16. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
17. Determination of triamcinolone acetonide in equine serum and urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.
Koupai-Abyazani MR; Yu N; Esaw B; Laviolette B
J Anal Toxicol; 1995; 19(3):182-6. PubMed ID: 7564297
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
19. Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection.
Cheng L; Banker AS; Martin M; Kozak I; Freeman WR
Ophthalmology; 2009 Jul; 116(7):1356-9. PubMed ID: 19450879
[TBL] [Abstract][Full Text] [Related]
20. Vitreous concentration of triamcinolone acetonide after a single transseptal depot injection.
Silva PS; Singh RJ; Bakri SJ; Lising RS; Santiago DE; Uy HS
Ocul Immunol Inflamm; 2009; 17(3):216-20. PubMed ID: 19585367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
